Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Vaginal Health Trial
NCT02516202Phase 3Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Apr 2016
- Primary completion
- May 2017
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of estradiol in Vulvovaginal atrophy (VVA), sponsored by Fred Hutchinson Cancer Center. Started Apr 2016; status: completed.
02
Drugs
estradiol
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT02516202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02516202.